{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:04:38Z","timestamp":1768878278115,"version":"3.49.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:p>\n            Unlike healthy subjects, overt congestive heart failure cannot \u201cescape\u201d the sodium- and water-retaining actions of mineralocorticoid excess. It is undefined whether escape occurs in asymptomatic left ventricular dysfunction (ALVD), which is characterized by preserved sodium homeostasis, natriuretic peptide activation, and normal circulating aldosterone. We hypothesized that, in ALVD, mineralocorticoid excess with exogenous deoxycorticosterone acetate (DOCA) would overwhelm renal compensatory mechanisms, resulting in sodium and water retention, and promote renal and cardiac collagen deposition. ALVD was induced in 2 groups (N=5 each) of dogs by tachypacing at 180 bpm. Urine was collected daily and blood drawn at baseline and days 2, 5, 8, and 11. One group served as control (ALVD), and the other received DOCA (ALVD+DOCA) starting at day 2 of pacing. Urine flow and sodium excretion were unchanged in the ALVD group. In ALVD+DOCA, urine flow and sodium excretion decreased on the first 2 days DOCA was given but normalized starting day 4. Urine flow and urinary cGMP excretion increased in ALVD+DOCA after DOCA escape. Plasma atrial natriuretic peptide, B-type natriuretic peptide, and cGMP increased equally in both groups. There were no differences in cardiorenal and hemodynamic parameters in an acute study on day 11. Although renal collagen area fraction was similar, left ventricular collagen area fraction in ALVD+DOCA was significantly higher than in ALVD (3.3\u00b10.4% versus 2.0\u00b10.2%;\n            <jats:italic>P<\/jats:italic>\n            =0.012). We conclude that ALVD can escape the sodium- and water-retaining effects of mineralocorticoid excess. Despite renal escape, increased left ventricular collagen deposition suggests that the heart but not the kidney failed to escape the tissue effects of DOCA.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.107.088534","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T00:58:43Z","timestamp":1184633923000},"page":"481-488","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Mineralocorticoid Escape by the Kidney But Not the Heart in Experimental Asymptomatic Left Ventricular Dysfunction"],"prefix":"10.1161","volume":"50","author":[{"given":"Lisa C.","family":"Costello-Boerrigter","sequence":"first","affiliation":[{"name":"From the Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minn."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Boerrigter","sequence":"additional","affiliation":[{"name":"From the Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minn."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail J.","family":"Harty","sequence":"additional","affiliation":[{"name":"From the Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minn."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Cataliotti","sequence":"additional","affiliation":[{"name":"From the Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minn."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret M.","family":"Redfield","sequence":"additional","affiliation":[{"name":"From the Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minn."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"John C.","family":"Burnett","sequence":"additional","affiliation":[{"name":"From the Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minn."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.09.011"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.2.194"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-11-200306030-00012"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000085166.44904.79"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm102"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.82.5.2146040"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)03034-1"},{"key":"e_1_3_2_8_2","unstructured":"Stevens TL Borgeson DD Luchner A Wennberg P Redfield MM Burnett JC Jr. A modified model of tachycardia-induced cardiomyopathy: Insights into humoral and renal adaptations. In: Spinale FG ed. Pathophysiology of Tachycardia-Induced Heart Failure. Armonk NY: Futura Publishing Co; 1996: 133\u2013151."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00269.x"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/26.7.671"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117269"},{"key":"e_1_3_2_12_2","first-page":"E883","volume":"271","year":"1996","unstructured":"Young MJ, Funder JW. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis. Am J Physiol. 1996; 271: E883\u2013E888.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118867"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00929.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1940.131.1.73"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI103747"},{"key":"e_1_3_2_17_2","first-page":"883","volume":"2","year":"1959","unstructured":"Nelson DH, August JT. Abnormal response of oedematous patients to aldosterone or deoxycortone. Lancet. 1959; 2: 883\u2013885.","journal-title":"Lancet"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1971.220.4.952"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1976.231.1.56"},{"key":"e_1_3_2_20_2","first-page":"H739","volume":"257","year":"1989","unstructured":"Villarreal D, Freeman RH, Brands MW. DOCA administration and atrial natriuretic factor in dogs with chronic heart failure. Am J Physiol. 1989; 257: H739\u2013H745.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.87.6.8504516"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117757"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.37.4.1089"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.100.24.2443"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.6.2_pt_2.i183"},{"key":"e_1_3_2_26_2","first-page":"F396","volume":"249","year":"1985","unstructured":"Burnett JC, Haas JA, Larson MS. Renal interstitial pressure in mineralocorticoid escape. Am J Physiol. 1985; 249: F396\u2013F399.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112650"},{"key":"e_1_3_2_28_2","first-page":"R878","volume":"252","year":"1987","unstructured":"Granger JP, Burnett JC Jr, Romero JC, Opgenorth TJ, Salazar J, Joyce M. Elevated levels of atrial natriuretic peptide during aldosterone escape. Am J Physiol. 1987; 252: R878\u2013R882.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_29_2","first-page":"R188","volume":"252","year":"1987","unstructured":"Metzler CH, Gardner DG, Keil LC, Baxter JD, Ramsay DJ. Increased synthesis and release of atrial peptide during DOCA escape in conscious dogs. Am J Physiol. 1987; 252: R188\u2013R192.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117544"},{"key":"e_1_3_2_31_2","first-page":"R197","volume":"276","year":"1999","unstructured":"Granger JP, Kassab S, Novak J, Reckelhoff JF, Tucker B, Miller MT. Role of nitric oxide in modulating renal function and arterial pressure during chronic aldosterone excess. Am J Physiol. 1999; 276: R197\u2013R202.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10366"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00096.2005"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl314"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.102.2.203"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00608-7"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.03.075"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.105.580506"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02053-5"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90167-L"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"e_1_3_2_43_2","first-page":"E657","volume":"269","year":"1995","unstructured":"Young M, Head G, Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol. 1995; 269: E657\u2013E662.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.105.600437"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.105.571653"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2006.01.013"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90742-8"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2845584"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.107.088534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T07:37:13Z","timestamp":1715585833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.107.088534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.107.088534"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.107.088534","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"2007-02-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-06-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}